Mechlorethamine is a type of medicine used to treat certain types of cancer, like lymphoma. It works by stopping cancer cells from growing. It's usually given as an injection or a pill.
Every report comes from a Lived member, sent anonymously.
Have you tried Mechlorethamine for Mycosis Fungoides?
Mechlorethamine is a cancer medicine that, in the US today, is sold as Valchlor, a gel applied to the skin. Valchlor treats early-stage mycosis fungoides (stage IA, with limited skin involvement, and stage IB, with more widespread patches), the most common type of cutaneous T-cell lymphoma. This is a cancer of immune cells called T cells that shows up first in the skin, usually as flat, scaly patches or slightly raised plaques. Its US approval covers only these early stages, where the disease is limited to patches and plaques on the skin. The gel is approved for people who have already tried another skin-directed treatment, such as steroid creams or light therapy (phototherapy). It is one of several options dermatologists and cancer specialists use to control skin lesions, and it is often chosen after strong steroid creams stop working or when light therapy is unsuitable. Mechlorethamine is also known as nitrogen mustard or chlormethine. An injectable version, formerly sold as Mustargen, was given by IV as part of older combination chemotherapy for Hodgkin lymphoma; it is no longer marketed in the US. The rest of this page describes the gel.
Mechlorethamine belongs to a group of chemotherapy drugs called alkylating agents. It attaches to DNA and links its two strands together, so a cell cannot copy its DNA and divide. Cells that divide quickly, including the abnormal T cells in mycosis fungoides lesions, are most affected, and the damaged cells die. Applied as a gel, the drug acts in the skin where it is spread. In studies, no measurable amount reached the bloodstream, which is why its side effects are concentrated in the skin rather than throughout the body as with IV chemotherapy. The trade-off is that it works only on the skin it is applied to.
Valchlor comes as a 0.016% gel in a tube. A thin layer is usually applied once a day to the affected patches, either as spot treatment for a few lesions or over wider areas when the disease is more widespread. Some specialists start less often, such as a few times a week, and build up to daily use to limit irritation. If the skin reacts, the doctor may pause treatment and then restart it less often. The gel is kept in the refrigerator, applied within 30 minutes of taking it out, and returned right away. It goes on completely dry skin: at least 30 minutes after a shower or bath, and at least 4 hours before the next one. Let it dry for 5 to 10 minutes before covering it with clothing, and do not put airtight or watertight bandages over treated skin. Moisturizers can be used 2 hours before or 2 hours after an application. The gel contains alcohol and is flammable, so stay away from open flames and do not smoke until it has dried. Because the gel is a cancer drug that can harm other people's skin, wash your hands well with soap and water after applying it. Anyone helping to apply it should wear disposable nitrile gloves and wash their hands after taking them off. If the gel touches someone else's skin, they should wash the area with soap and water for at least 15 minutes and remove any contaminated clothing. Unused gel is thrown out after 90 days, and tubes and used gloves go in the trash where children and pets cannot reach them. If you miss an application, apply it when you remember unless the next one is nearly due. Do not use extra gel to make up for it.
Skin irritation (dermatitis) is the most common side effect. In the main trial, more than half of users developed redness, itching, swelling or inflammation where the gel was applied, and about 1 in 4 had a moderately severe or severe reaction. Irritation tends to peak in the second and third months. The face, genitals, anal area and skin folds are especially prone to it. Doctors sometimes add a steroid ointment such as triamcinolone, which in a small study reduced irritation without making the gel less effective. Other common effects are itching, bacterial skin infections and darkening of treated skin. Stop using the gel and contact your doctor promptly if treated skin blisters, forms open sores (ulcers), or becomes markedly red and swollen. Treatment can often be resumed at a lower frequency once the skin settles. Severe allergic reactions, including anaphylaxis, have been reported with mechlorethamine applied to the skin. Hives or any difficulty breathing or swallowing after an application means stopping the gel and getting emergency medical treatment.
Getting the gel in the eyes, nose or mouth is the most serious hazard. In the eyes it can cause pain, burning, light sensitivity and blurred vision, and can lead to permanent eye damage or blindness. If it gets in the eyes, rinse them right away for at least 15 minutes with plenty of water, saline or eyewash, then get emergency medical help, including an eye specialist. If it gets in the nose or mouth, rinse with plenty of water for at least 15 minutes and get emergency medical help. It is worth agreeing with the care team in advance how you would get help quickly. Non-melanoma skin cancers, such as squamous cell carcinoma, have developed in some people using mechlorethamine, sometimes on skin that was never treated. Many of them had also had other treatments that raise skin cancer risk, and how much the drug itself contributes is uncertain. Doctors check the skin during and after treatment, and any new skin changes or growths should be reported. Mechlorethamine can harm a developing baby. People who could become pregnant should avoid pregnancy while using it and contact the doctor right away if pregnancy occurs. Men with partners who could become pregnant should use a barrier method such as condoms during treatment. Breastfeeding is not advised during treatment, because a baby could be exposed through contact with the parent's skin. Drug interactions are unlikely because the gel is not measurably absorbed into the blood. The care team should still know about other skin treatments, such as steroid creams, retinoids and light therapy, which are often combined with it. The gel should not be used by anyone who has had a severe allergic reaction to mechlorethamine.
Results come slowly. Some people notice changes within 4 to 6 weeks, but in the main trial responses began anywhere from 1 to 11 months after starting. About 6 in 10 people saw their lesions at least halve in severity over a year of treatment; complete clearing was less common, around 1 in 7. With older ointment forms of the drug, stage IA disease responded better than more widespread stage IB disease. When the gel is used over large areas, patches that were not visible before can appear. This can be the treatment revealing existing disease rather than the lymphoma getting worse, so it is worth discussing with the doctor before stopping. Many people use the gel for a year or longer, often moving it to new or remaining patches over time and combining it with other skin treatments. Follow-up visits track the lesions, help manage irritation and include skin cancer checks. Mycosis fungoides is usually a long-term condition, and skin treatments like this one can bring lesions under control for a time rather than guaranteeing they stay away. The gel is also expensive, so confirming insurance coverage early can avoid delays.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Mechlorethamine, what you've noticed, or ask the community a question.